CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Systemic indirect endovenous ozone therapyWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Randomized Clinical Trial to Evaluate Efficacy and Safety of Systemic Indirect Endovenous Ozone Therapy (SIEVOT) as Adjuvant Treatment in COVID19 Non-intubated Patients

Systemic medical ozone has proved to help in several viral diseases, chronic obstructive pulmonary disease and chronic inflammation process. The investigators are sure that its application to COVID-19 patients, as an adjuvant therapy, will improve the health status of these individuals.

NCT04359303 COVID Other: Systemic indirect endovenous ozone therapy

Primary Outcomes

Description: World Health Organization (WHO) recommended COVID19 clinical scale

Measure: COVID19 clinical scale

Time: through study completion, an average of 3 weeks

Secondary Outcomes

Description: Dead patients during the trial

Measure: Number of died patients

Time: through study completion, an average of 3 weeks

Description: Oro/nasopharynx virus

Measure: Oro/nasopharynx virus

Time: through study completion, an average of 3 weeks

Description: Thorax imaging according scale. Higher punctuation is worse.

Measure: Thorax imaging (0=none; 1=unilateral; 2=bilateral; 3=ground-glass opacification; 4=consolidation)

Time: through study completion, an average of 3 weeks

Description: Days in hospital

Measure: Days in hospital

Time: through study completion, an average of 3 weeks

Description: Venous gas blood analysis

Measure: Venous gas blood analysis

Time: through study completion, an average of 3 weeks


No related HPO nodes (Using clinical trials)